Charles River Laboratories | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Agilent USD 376M 32M 2025-01
Align Technology USD 131.1M 13.05M 2025-03
Bio-Rad Laboratories USD 23.7M 34.7M 2025-03
Bruker USD 64.1M 4M 2024-12
Cardinal Health USD 730M 181M 2025-03
Charles River Laboratories USD -167687000 285.09M 2024-12
Cigna USD 2.01B 291M 2025-03
CVS Health USD 3.37B 515M 2025-03
Danaher USD 1.28B 142M 2025-03
Dentsply International USD -509000000 47M 2024-12
Elevance Health USD 3.14B 2.2B 2025-03
Galapagos EUR -158708000 95.99M 2025-03
Hologic USD -7000000 236.8M 2025-03
Humana USD 2.01B 2.56B 2025-03
Illumina USD 175M 566M 2024-12
Incyte USD 205.17M 96.34M 2025-03
IQVIA Holdings USD 626M 76M 2024-12
Laboratory Of America USD 332.4M 115.9M 2025-03
Lonza CHF 534M 194M 2024-06
McKesson USD 1.22B 646M 2024-12
Merck EUR 1.2B 100M 2024-12
Mettler Toledo International USD 201.94M 112.6M 2025-03
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Quest Diagnostics USD 346M 15M 2025-03
Revvity USD 72.23M 46.52M 2025-03
Thermo Fisher Scientific USD 1.72B 300M 2025-03
United Therapeutics USD 382.8M 25.1M 2025-03
UnitedHealth USD 9.1B 1.31B 2025-03
Walgreens Boots Alliance USD -5208000000 5B 2025-02
Waters USD 292.26M 81.13M 2024-12
West Pharmaceutical Services USD 107M 52.6M 2025-03



Charles River Laboratories Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.